Leading pharmaceutical companies, including Dr Reddy's, Sun Pharma, Cipla, Mankind Pharma, and Natco Pharma, among others, ...

Before the hearing, Oz hadn’t spoken much about pressing health policy issues since he was nominated for the crucial post.

Weight loss from glucagon-like peptide 1 agonists clearly alleviates knee osteoarthritis pain, but other recently published data give pause regarding possible long-term adverse effects.

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility. However, three Fool.com ...

They’re expensive and aren’t a short-term fix, but Ozempic and Wegovy show great promise in regulating weight. | Opinion ...

Semaglutide: A Game-Changer for Weight Loss and Health ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Two best friends who took weight loss drugs to lose the extra weight had very different experiences, and now, they've spoken ...

The federal agency’s new alert is about counterfeit drugs claiming to have semaglutide — the key ingredient in weight loss ...

(HealthDay News) — Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online in JAMA Surgery.